Utah Retirement Systems’s Jazz Pharmaceuticals JAZZ Stock Holding History

Utah Retirement Systems’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$586K	Hold	3,100	–	–	0.01%	716
2025 Q4	$527K	Hold	3,100	–	–	0.01%	750
2025 Q3	$409K	Sell	3,100 -6,702	-68%	-$804K	﹤0.01%	788
2025 Q2	$1.04M	Hold	9,802	–	–	0.01%	694
2025 Q1	$1.22M	Sell	9,802 -234	-2%	-$30.5K	0.01%	678
2024 Q4	$1.24M	Sell	10,036 -100	-1%	-$11.8K	0.01%	683
2024 Q3	$1.13M	Buy	10,136 +100	+1%	+$11K	0.01%	709
2024 Q2	$1.07M	Sell	10,036 -500	-5%	-$55K	0.01%	709
2024 Q1	$1.27M	Hold	10,536	–	–	0.01%	695
2023 Q4	$1.3M	Buy	10,536 +100	+1%	+$12.5K	0.02%	686
2023 Q3	$1.35M	Hold	10,436	–	–	0.02%	640
2023 Q2	$1.29M	Sell	10,436 -400	-4%	-$53.8K	0.02%	671
2023 Q1	$1.59M	Hold	10,836	–	–	0.02%	606
2022 Q4	$1.73M	Buy	10,836 +100	+0.9%	+$14.7K	0.03%	531
2022 Q3	$1.43M	Hold	10,736	–	–	0.02%	581
2022 Q2	$1.68M	Hold	10,736	–	–	0.03%	540
2022 Q1	$1.67M	Hold	10,736	–	–	0.02%	594
2021 Q4	$1.37M	Hold	10,736	–	–	0.02%	699
2021 Q3	$1.4M	Sell	10,736 -600	-5%	-$90.7K	0.02%	686
2021 Q2	$2.01M	Buy	11,336 +700	+7%	+$121K	0.03%	584
2021 Q1	$1.75M	Sell	10,636 -200	-2%	-$32.9K	0.02%	605
2020 Q4	$1.79M	Buy	10,836 +500	+5%	+$74.5K	0.03%	563
2020 Q3	$1.47M	Hold	10,336	–	–	0.02%	572
2020 Q2	$1.14M	Sell	10,336 -200	-2%	-$22.1K	0.02%	615
2020 Q1	$1.05M	Hold	10,536	–	–	0.02%	578
2019 Q4	$1.57M	Buy	10,536 +100	+1%	+$13.6K	0.03%	572
2019 Q3	$1.34M	Sell	10,436 -200	-2%	-$26.8K	0.03%	614
2019 Q2	$1.52M	Sell	10,636 -472	-4%	-$63.4K	0.03%	570
2019 Q1	$1.59M	Buy	11,108 +108	+1%	+$14.1K	0.03%	539
2018 Q4	$1.36M	Hold	11,000	–	–	0.03%	531
2018 Q3	$1.85M	Buy	11,000 +200	+2%	+$34.4K	0.04%	486
2018 Q2	$1.86M	Buy	+10,800	New	+$1.77M	0.04%	471
2016 Q2	–	Sell	-11,000	Closed	-$1.44M	–	1014
2016 Q1	$1.44M	Hold	11,000	–	–	0.04%	478
2015 Q4	$1.55M	Hold	11,000	–	–	0.04%	451
2015 Q3	$1.46M	Buy	11,000 +100	+0.9%	+$17.2K	0.04%	463
2015 Q2	$1.92M	Buy	10,900 +300	+3%	+$53.9K	0.05%	391
2015 Q1	$1.83M	Buy	10,600 +300	+3%	+$51.5K	0.05%	410
2014 Q4	$1.69M	Hold	10,300	–	–	0.05%	415
2014 Q3	$1.65M	Hold	10,300	–	–	0.05%	405
2014 Q2	$1.51M	Buy	10,300 +900	+10%	+$125K	0.04%	450
2014 Q1	$1.3M	Buy	9,400 +100	+1%	+$15.1K	0.04%	496
2013 Q4	$1.18M	Hold	9,300	–	–	0.03%	518
2013 Q3	$855K	Sell	9,300 -100	-1%	-$8.07K	0.03%	618
2013 Q2	$646K	Buy	+9,400	New	+$575K	0.02%	735

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Utah Retirement Systems's JAZZ Position: Q1 2026 in Review

Utah Retirement Systems held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 3,100 shares worth $586K. The position accounts for 0.01% of the portfolio, ranked #716.

Utah Retirement Systems first reported a position in JAZZ in Q2 2013 and has held it in 44 quarters since. The position peaked at $2.01M in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Utah Retirement Systems held 3,100 shares of Jazz Pharmaceuticals worth $586K as of Q1 2026.
Utah Retirement Systems left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up 0.01% of Utah Retirement Systems's portfolio in Q1 2026, its #716 holding.
Utah Retirement Systems first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 44 quarters since.
Utah Retirement Systems's Jazz Pharmaceuticals position peaked at $2.01M in Q2 2021.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Utah Retirement Systems's 13F filing for Q1 2026, filed 15 May 2026.